JPWO2022121981A5 - - Google Patents

Info

Publication number
JPWO2022121981A5
JPWO2022121981A5 JP2023535475A JP2023535475A JPWO2022121981A5 JP WO2022121981 A5 JPWO2022121981 A5 JP WO2022121981A5 JP 2023535475 A JP2023535475 A JP 2023535475A JP 2023535475 A JP2023535475 A JP 2023535475A JP WO2022121981 A5 JPWO2022121981 A5 JP WO2022121981A5
Authority
JP
Japan
Prior art keywords
compound
formula
pharmaceutically acceptable
solvate
hydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023535475A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023552610A5 (https=
JP2023552610A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/136769 external-priority patent/WO2022121981A1/zh
Publication of JP2023552610A publication Critical patent/JP2023552610A/ja
Publication of JPWO2022121981A5 publication Critical patent/JPWO2022121981A5/ja
Publication of JP2023552610A5 publication Critical patent/JP2023552610A5/ja
Pending legal-status Critical Current

Links

JP2023535475A 2020-12-11 2021-12-09 新規カンプトテシン誘導体、それを含む組成物およびその使用 Pending JP2023552610A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202011463704.4 2020-12-11
CN202011463704 2020-12-11
PCT/CN2021/136769 WO2022121981A1 (zh) 2020-12-11 2021-12-09 新型喜树碱衍生物、含其的组合物和其用途

Publications (3)

Publication Number Publication Date
JP2023552610A JP2023552610A (ja) 2023-12-18
JPWO2022121981A5 true JPWO2022121981A5 (https=) 2026-01-16
JP2023552610A5 JP2023552610A5 (https=) 2026-01-16

Family

ID=81974225

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023535475A Pending JP2023552610A (ja) 2020-12-11 2021-12-09 新規カンプトテシン誘導体、それを含む組成物およびその使用

Country Status (9)

Country Link
US (1) US20230416270A1 (https=)
EP (1) EP4265620A4 (https=)
JP (1) JP2023552610A (https=)
KR (1) KR20230118891A (https=)
CN (1) CN116583526B (https=)
AU (1) AU2021394411A1 (https=)
CA (1) CA3200649A1 (https=)
MX (1) MX2023006751A (https=)
WO (1) WO2022121981A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025523863A (ja) * 2022-07-11 2025-07-25 ピノットバイオ インコーポレイテッド Ddx5タンパク質に結合するカンプトセシン誘導体およびそのプロドラッグ
KR102630719B1 (ko) * 2022-07-11 2024-01-30 주식회사 피노바이오 Ddx5 단백질에 결합하는 캄토테신 유도체 및 이의 프로드럭
EP4692091A1 (en) * 2023-04-07 2026-02-11 Changchun Genescience Pharmaceutical Co., Ltd. Camptothecin derivative, and pharmaceutical composition, preparation method therefor and use thereof
WO2025084851A1 (ko) * 2023-10-19 2025-04-24 (주)셀트리온 캄프토테신 유도체를 포함하는 항-c-met 항체-약물 접합체
KR20250057675A (ko) * 2023-10-19 2025-04-29 (주)셀트리온 캄프토테신 유도체를 포함하는 항-Tissue factor 항체-약물 접합체
WO2025084859A1 (ko) * 2023-10-19 2025-04-24 (주)셀트리온 캄프토테신 유도체를 포함하는 항-nectin-4 항체-약물 접합체
WO2025261469A1 (zh) * 2024-06-20 2025-12-26 科霸生物(江苏)有限公司 喜树碱衍生物、抗体、药物偶联物、及其组合物和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3008226B2 (ja) * 1991-01-16 2000-02-14 第一製薬株式会社 六環性化合物
JP3359955B2 (ja) * 1992-07-16 2002-12-24 第一製薬株式会社 抗腫瘍剤
DE19640207A1 (de) * 1996-09-30 1998-04-02 Bayer Ag Glycokonjugate von modifizierten Camptothecin-Derivaten (A- oder B-Ring-Verknüpfung)
JP2000044567A (ja) * 1998-07-29 2000-02-15 Dai Ichi Seiyaku Co Ltd 六環性化合物
SI3466976T1 (sl) * 2014-01-31 2021-12-31 Daiichi Sankyo Company, Limited Anti-her2 konjugat protitelesa-zdravila
JP6612738B2 (ja) * 2014-04-10 2019-11-27 第一三共株式会社 抗her2抗体−薬物コンジュゲート
SG10201912173RA (en) * 2016-10-07 2020-02-27 Daiichi Sankyo Co Ltd Therapy for drug-resistant cancer by administration of anti-her2 antibody/drug conjugate
CA3107417C (en) * 2018-07-25 2023-10-17 Daiichi Sankyo Company, Limited Effective method for manufacturing antibody-drug conjugate
WO2020063676A1 (zh) * 2018-09-26 2020-04-02 江苏恒瑞医药股份有限公司 依喜替康类似物的配体-药物偶联物及其制备方法和应用
CN112543771B (zh) * 2018-09-30 2023-04-11 江苏豪森药业集团有限公司 抗b7h3抗体-依喜替康类似物偶联物及其医药用途
CN111689980A (zh) * 2019-05-26 2020-09-22 四川百利药业有限责任公司 一种喜树碱药物及其抗体偶联物
CA3144790A1 (en) * 2019-06-28 2020-12-30 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Antibody-drug conjugate, intermediate thereof, preparation method therefor and application thereof
CN116888123B (zh) * 2021-02-09 2026-02-24 微境生物医药科技(上海)有限公司 用于adc制备的喜树碱衍生物

Similar Documents

Publication Publication Date Title
JP2024050527A5 (https=)
JP2004516314A5 (https=)
JP2006501181A5 (https=)
RU2005107314A (ru) Пиримидопроизводные, характеризующиеся антипролиферативной активностью
JP2022081661A5 (https=)
JPWO2023099592A5 (https=)
JP2002030084A5 (https=)
ME00876B (me) 4"supstituisani-9-deokso-9a-aza-9a-homoeritromicin a derivati
JP2006509749A5 (https=)
JP2010540508A5 (https=)
JP2002539128A5 (https=)
EP2888239B1 (en) Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
CA2422375A1 (en) 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents
RU98102128A (ru) Производные бензо[g]хинолина
RU2008152763A (ru) Применение агонистов каннабиноидного рецептора в качестве индуцирующих гипотермию лекарственных средств для лечения ишемии
JP2005536503A5 (https=)
JPWO2021030555A5 (https=)
JPH0920659A5 (https=)
JPWO2022121981A5 (https=)
JP2007507474A5 (https=)
JP2004523478A5 (https=)
JP2004525178A5 (https=)
JP2005516898A5 (https=)
JPH1087577A5 (https=)
RU2010154417A (ru) Комбинация частичного агониста никотиновых рецепторов и ингибитора ацетилхолинетеразы, содержащая ее фармацетическая композиция, и ее применение в лечении когнитивных расстройств